Moderna cancer vaccine shows positive results in melanoma trial
Moderna said its personalized mRNA cancer vaccine lowered the risk of melanoma returning or spreading when used with Keytruda in a late-stage trial.
By the ClickNNY North Country Desk
Moderna said its personalized mRNA cancer vaccine reduced the risk of melanoma returning or spreading in a late-stage trial. The vaccine was tested with Merck’s Keytruda, an immunotherapy treatment, compared with Keytruda alone.
The companies said the treatment could be available as soon as next year if regulators approve it. Because the vaccine is tailored to each patient, producing it on a large scale could be difficult. The results sent Moderna shares sharply higher, with the stock rising as much as 160%.
This story was written from a community submission and reviewed by a ClickNNY editor before publication.
More from ClickNNY
Guides and features from across the North Country.
ClickNNY Guide · Fort Drum
Your first North Country winter: a survival guide for Fort Drum soldiers from the South
Never driven on snow, owned a snow blower or felt a February morning at Fort Drum? Here's what to wear, what to keep in your car and how to get through your first lake-effect winter.
ClickNNY Guide · Winter
Are we ready for another North Country winter?
From heating bills and snow tires to lake-effect storms and the first big snowfall, Northern New York is getting ready for another winter. But how prepared are we really?
ClickNNY Guide
Driving on wet leaves in the North Country: what to know this fall
Wet leaves, farm equipment, school buses, low sunlight, frost and deer can create seasonal driving hazards in Northern New York, according to safety guidance from AAA Northeast, AARP, New York agencies and the National Highway Traffic Safety Administration.